tebu-bio is a European company specialised in providing innovative reagents and laboratory services in Life Sciences
X

Need an answer now?

Give us a call

Leave a message, we'll get back to you





Move

Product added to your basket !


Continue your visit View your basket
50ul EUR 314
314€


Contact us

Recent History

Anti TUBB2A (Acetyl-K379)

Product name
Anti TUBB2A (Acetyl-K379)
Catalog number
BS64103-50ul (50ul)
Description
Tubulin is a major cytoskeleton component that has five distinct forms, designated a, b, g, d and e tubulin. a and b tubulins form heterodimers which multimerize to form a microtubule filament. Multiple b Tubulin isoforms (b1, b2, b3, b4, b5, b6 and b8) have been characterized and are expressed in mammalian tissues. b1 and b4 are present throughout the cytosol, b2 is present in the nuclei and nucleoplasm, and b3 is a neuron-specific cytoskeletal protein. g Tubulin forms the gammasome, which is required for nucleating microtubule filaments at the centrosome. Both d Tubulin and e Tubulin are associated with the centrosome. d Tubulin is a homolog of the Chlamydomonas d Tubulin Uni3 and is found in association with the centrioles, whereas e Tubulin localizes to the pericentriolar material. e Tubulin exhibits a cell cycle-specific pattern of localization; first associating with only the older of the centrosomes in a newly duplicated pair, and later associating with both centrosomes.1 mg/ 
Source
Bioworld technology
Product category
Antibodies
Product sub category
Primary Antibodies
Target species
Human, Mouse, Rat
Target's name
Tubulin beta-2A chain, Tubulin beta class IIa, TUBB2A, Tubulin beta-2B chain, TUBB2B, Tubulin beta-3 chain, Tubulin beta-4 chain, Tubulin beta-III, TUBB3, Tubulin beta-4B chain, Tubulin beta-2 chain, Tubulin beta-2C chain, TUBB4B, Tubulin beta chain, Tubulin beta-5 chain, TUBB, Tubulin beta-6 chain, Tubulin beta class V, TUBB6
Host
Rabbit
Clonality
Polyclonal
Application
WB
Shipment info
Cool Pack
Nacres Codification
NA.41

Request the Datasheet

First name
Last name
Email *
Country *:
Company name *
  
* Fields marked with an asterisk are required.



Protocol

To access the protocol, please provide your email address :